Friday, 20th November International Celiac Disease Symposium 2026

Invited Speakers:

• Dr Jorunn Stamnaes, University of Oslo - 'Proteomics in Celiac Disease'
• Dr Michael Fitzpatrick, University of Oxford - 'Spatial Omics in Celiac Disease'
• Professor Anthony Purcell, Monash University - 'Immunopeptidomics in Celiac Disease'

Abstract Speakers:

• A distinct cellular ecosystem underlies tissue healing in celiac disease. - Veronica Locher
• Transcriptomic stratification of celiac disease reveals sex-, age-, and severity-dependent programs - Valentina Discepolo
• Rare but functional anti-tumour T-cell clones in the duodenal mucosa of type II refractory coeliac disease - Vanessa Mhanna and Anaïs Levescot

Invited Speakers:

• Professor Peter Gibson, Monash University - 'Disease Overlap with Celiac Disease: NCGS, IBD, IBS'
• Professor Joseph Murray, Mayo Clinic - 'Potential, Ultrashort and Asymptomatic Celiac Disease: Definitions, diagnosis, and approaches to management'
• Dr Simon Knowles, Swinburne University - 'Psychological Issues and Brain Fog in Celiac Disease'
• Dr Rose-Marie Satherley, University of Surrey - 'Understanding and Managing ARFID'

Abstract Speakers:

• X-ray crystal structures elucidate how autoantibodies enhance the activity of transglutaminase 3 in dermatitis herpetiformis - Julie Elisabeth Heggelund
• CHILDREN WITH DOWN SYNDROME DISPLAY A DISTINCT INTESTINAL MUCOSAL PHENOTYPE BEYOND CELIAC DISEASE - Roberta Rotondo
• From Single-Marker Testing to Multiparametric Serology in Dermatitis Herpetiformis - Patricia Wusterhausen

Invited Speakers:

• Dr Claire Jansson-Knodell, Cleveland Clinic - 'Best Practice for Detecting and Diagnosing Celiac Disease'
• Professor Ritu Verma, Comer Children's Hospital, University of Chicago - 'Common Management Challenges for Doctors'
• Mr Cristian Costas, Bradford Teaching Hospitals NHS Foundation Trust - 'When Should a Dietitian Get Involved?'
• Professor Andrew Day, University of Otago, Christchurch - 'Common Pediatric Issues in Celiac Disease Diagnosis and Management'
• Ms Sadie Nagle, Children's Hospital Colorado - 'Common Pediatric Dietary Issues in Celiac Disease'
• Dr Mohamed Shiha, University of Sheffield - 'What is Best-Practice Follow-Up in Celiac Disease?'

Invited Speakers:

• Professor Paul Turner, Imperial College London - 'Perspectives from the Food Allergy Field'
• Ms Jasmine Lacis-Lee, Merieux NutriSciences AQ & Allergen Bureau - 'The Gluten Reference Dose and GF Threshold from a Regulatory Perspective'

Followed by Panel Discussion.

Abstract Speakers:

• A Randomized, Double-Blind, Placebo-Controlled, Biological Proof-of-Concept Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biological Effects of DONQ52 in Celiac Disease Patients with Gluten Challenge (the DQB103CT Study) - Jason Tye-Din
• Ritlecitinib Attenuates Gluten-Induced Histologic and Immunologic Disease Activity in Celiac Disease: A Phase 2 Proof-of-Concept Study - Maureen M Leonard
• Evaluation of ANB033, an Investigational CD122 Antagonist Monoclonal Antibody, for the Treatment of Celiac Disease: A Novel Phase 1 Clinical Study Design - Juha Taavela
• TEV-53408, an Anti-IL-15, Significantly Attenuated Gluten-Induced Villous Change in Adults With Celiac Disease: Results From a Phase 2a Randomized, Placebo-Controlled Study - Juha Taavela

Invited Speakers:

• TBC
• Dr Amelie Therrien, Celiac Center, Beth Israel Deaconess Medical Center - 'Celiac Beyond the Gut: Understanding and Managing Whole Body Symptoms'
• Mr Cristian Costas, Bradford Teaching Hospitals NHS Foundation Trust - 'Optimising the Gluten-Free Diet for Health and Enjoyment'
• Ms Vanessa Weisbrod, Celiac Disease Foundation - 'How Research on Cross-Contact, Social Life, and School Accommodations Can Protect You'
• Dr Maureen Leonard, Mass General Brigham/Harvard - 'Can We Prevent and Predict Celiac Disease in Children?'

Followed by Panel Discussion.

• Coeliac disease autoimmunity and coeliac disease in the Environmental Determinants of Islet Autoimmunity pregnancy-to-childhood cohort study of Australian children at risk of type 1 diabetes - Rebecca Thomson
• Early-Life Screening for Celiac Disease in Genetically At-risk Children: the BABYSCREEN Study - Laura Kivelä
• Prevalence of Celiac disease in second generation south Indian migrants’ parallels that of native North Indians: A community-based epidemiological study - Samagra Agarwal
• Prenatal and early life vitamin A intake is not associated with the risk of celiac disease: The Norwegian Mother, Father, and Child cohort study - Elin HÅRD AF SEGERSTAD
• Does Early-Life Greenspace Shape Celiac Disease Risk? Evidence From a Swedish Birth Cohort - Nan Du
• Long-term gluten exposure without villous atrophy in adults with coeliac disease - Luca LE Elli
• The Recipe for Retention: Dietitian-Led Gluten-Free Diet Education as a Stronger Predictor of Pediatric Celiac Follow-Up Than Location, Insurance, or Comorbidities - Sadie Nagle
• Gluten-induced disruption of intestinal neuronal signalling affects the brain and is reversible by transglutaminase inhibition in coeliac disease - Aline Pesi

Invite only.

Invited Speakers:

• Associate Professor Anne Lee, Celiac Disease Foundation - 'Towards Global Harmonisation: Standardising Dietitian Assessments in Celiac Disease'
• Mr Nick Trott, Sheffield Teaching Hospitals NHS Foundation Trust - 'Models of Follow-Up: Can a Dietitian-Led Celiac Clinic Work?'
• Ms Penny Dellsperger, ISSCD - 'Towards a Global Reference Dose for Gluten. What Might This Mean?'

Abstract Speakers:

• Fact or Philosophy? An International Survey of How Dietitians Teach Cross-Contact in the Gluten-Free Diet - Sadie Nagle
• Virtual celiac dietitian: A language-agnostic conversational agent powered by augmented intelligence for personalised food recommendations in patients with celiac disease - Samagra Agarwal
• Gluten tolerance in non-adherent coeliac patients: A Systematic Review and Meta-analysis. - Luca LE Elli
• Quantifying Dietary Gluten Exposure from Shared Fryers: Implications for Nutritional Management and Health Outcomes in Celiac Disease   - Vanessa Weisbrod

Invited Speakers:

• FDA Speaker TBC & FDA Speaker TBC
• Dr Daniel Leffler, Beth Israel Deaconess Medical Center - 'Validating PROs in Celiac Disease'
• Dr Daniel Adelman - 'Bridging Celiac Disease and Allergy: Lessons for Novel Therapies' 
• Professor Knut Lundin, University of Oslo - 'Gluten Challenge and Immune Readouts in Celiac Disease'

Followed by Panel Discussion.